Superior antitumor activity of co-loaded PTX/CP drug micelles compared to single drug micelles, or their mixture, was demonstrated in cisplatin-resistant human ovarian carcinoma A2780/CisR xenograft tumor and multidrug-resistant breast cancer LCC-6-MDR orthotopic tumor models (Wan et al., 2019). The gene discussed is CP; the disease is neoplasm.